{
}
Bettina Orlopp, CEO of Commerzbank, expressed concerns over a potential takeover by Unicredit, citing integration challenges and risks to German SMEs due to overlapping corporate clients. She noted that such a merger could lead to a downgrade in Commerzbank's rating and increased refinancing costs. Despite these risks, the bank's shares remain a strong buy, with a target price above €20.
Ramsay Santé reported a 6.5% increase in sales for the 2024 financial year, reaching 5 billion euros, driven by growth across all regions. However, the company faced a net loss of 53.9 million euros, down from a profit of 49.4 million euros last year, due to lower subsidies, rising costs, and staff shortages, leading to a decline in Ebitda margin from 13.2% to 12.2%. CEO Pascal Roché highlighted ongoing underfunding in the healthcare sector despite efforts to secure recognition for private hospitals' contributions.
TME Pharma N.V. reported significant advancements in its clinical and regulatory efforts for NOX-A12, a treatment for glioblastoma, achieving a median overall survival of 19.9 months in a recent trial. The FDA granted Fast Track designation and cleared an IND application for a Phase 2 study, paving the way for accelerated development. The company also raised €5 million in funding, enhancing its financial position as it prepares for further clinical trials.
UBS has rated Pernod Ricard as 'Neutral' with a target price of 138 euros. The company leads in premium and prestige spirits and wines, with net sales primarily from international brands (61.8%), local brands (18.2%), craft spirits (7.3%), and strategic wines (3.6%). Geographically, sales are distributed across Europe (28.3%), America (28.8%), and other regions (42.9%), supported by 94 production sites worldwide.
UBS has upgraded Sanofi to a 'Buy' rating with a target price of 110 euros, citing the neurodermatitis drug Dupixent as a key growth driver for the company in the third quarter. Analyst Carl Walton anticipates that growth will accelerate further in 2025.
UBS has upgraded its rating for Sanofi to "Buy," setting a target price of 110 euros. Analyst Carl Walton highlighted that the neurodermatitis drug Dupixent is expected to drive growth for the company in the third quarter, with acceleration anticipated in 2025.
UBS has lowered its target price for Nestlé S.A. to 83 francs, maintaining a 'Neutral' rating. Nestlé, the world's largest food group, generates sales across various sectors, including beverages (26.7%), pet food (20.3%), and pharmaceutical products (16.4%), with significant market presence in the USA and Canada (35%).
UBS has maintained a "Neutral" rating for Pernod Ricard, setting a target price of 138 euros. Analyst Sanjeet Aujla noted that the sales outlook for the spirits supplier remains challenging, although efforts to stabilize margins are viewed positively. Currently, the share valuation is slightly below average.
UBS has maintained a "Buy" rating for Sanofi, setting a price target of 110 euros ahead of the company's upcoming financial results. Analyst Carl Walton highlighted that the neurodermatitis drug Dupixent is expected to drive growth for the pharmaceutical firm in the third quarter, with acceleration anticipated in 2025.
EssilorLuxottica reported third-quarter sales of 6,437 million euros, falling 2% short of forecasts, with constant exchange rate growth at 4.0%. UBS maintains a Buy rating with a price target of 232 euros, suggesting that the promising start to the quarter may bolster the share price despite concerns over margin expansion in the second half of 2024. Investors may find reassurance in fourth-quarter forecasts amid a challenging environment.
FRA
Country
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
manager warns of risks in potential unicredit takeover of commerzbank
Euro
United States Dollar
Semperit Aktiengesellschaft Holding
Commerzbank AG
Deutsche Bank Aktiengesellschaft
UniCredit S.p.A.
Dresdner Bank
ESP
RUS
ITA
AUT
FRA
CHE
USA
GBR
DEU
Bettina Orlopp
Semperit AG Holding
Show more
13:21 19.10.2024
Ramsay Santé reports net loss amid rising sales and operational challenges
18:17 18.10.2024
TME Pharma advances glioblastoma treatment with promising NOX-A12 trial results
Euro
TME Pharma N.V.
Primarybid Ltd.
TME Pharma AG
TME Pharma Inc.
Singapore Eye Research Institute
National Cancer Institute
Atlas Special Opportunities II LLC
USA
FRA
DEU
SGP
Frank Giordano
Joe Biden
Show more
18:00 18.10.2024
ubs rates pernod ricard neutral with target price of 138 euros
11:58 18.10.2024
ubs upgrades sanofi to buy with target price of 110 euros
11:57 18.10.2024
ubs upgrades sanofi to buy with target price of 110 euros
11:57 18.10.2024
ubs lowers nestle target price to 83 francs maintaining neutral rating
11:13 18.10.2024
UBS maintains neutral rating for Pernod Ricard with target price of 138 euros
11:10 18.10.2024
UBS maintains buy rating for Sanofi with price target of 110 euros
11:09 18.10.2024
ubs maintains buy rating on essilorluxottica after third quarter results
10:56 18.10.2024
Trending
Subcategory
Industry Trends
Corporate News
Supply Chain Management
Global Trade Developments
Startups & Entrepreneurship
Government Economic Policies
Industry Mergers & Acquisitions
Retail and Consumer Goods
Finance Mergers & Acquisitions
Financial Scams and Security
Fintech Startups
Emerging Startups
Workplace Trends
CEO Changes
Venture Capital Investments
Cryptocurrency Trends
Funding Rounds & Investments
Energy Sector Developments
Market Analysis and Predictions
Stock Market Updates
Countries:
Companies:
Apple Inc.
Google Inc.
NVIDIA Corporation
Delhivery Limited
Ecom Express Ltd.
Alphabet Inc.
OpenAI ERC USD
Ciscom Corp.
ERICSSON - CLASS B
Physicswallah Ltd.
Learning Resources Inc.
MGA Entertainment Inc.
State Street Global Advisors Luxembourg SICAV - SSGA EMU ESG Screened Equity Fund
Snap Inc.
Tiktok USD
Semiconductor Manufacturing International Corporation
Hua Hong Semiconductor Ltd.
Spotify Technology S.A.
Dropbox, Inc.
Vimeo, Inc.
Currencies:
United States Dollar
Indian Rupee
Chinese Yuan
Euro
United Arab Emirates Dirham
Vietnamese Đồng
New Taiwan Dollar
Russian Ruble
South Korean Won
Pakistani Rupee
Algerian Dinar
Australian Dollar
Thai Baht
Japanese Yen
Saudi Riyal
People:
Donald Trump
Ilya Sutskever
Peter Thiel
Amal El Fallah Seghrouchni
Trixie Lohmirmand
Scott Bessent
Jamieson Greer
Joe Jurken
Stephen Roachford
David French
Rick Woldenberg
Marc Rosenberg
Isaac Larian
Hichem Djouhri
Laurina Emmanuel
Tim Cook
Andrew Ferguson
Sheryl Sandberg
Mark Zuckerberg
Pavel Prass